Therapeutic areas – FAQs
At Almirall, we focus our expertise on dermatology and related therapeutic areas in which we believe we can make meaningful improvements to patients’ lives. Find answers tO your questions about the clinical fields we work in and how we contribute to treatments and medical progress.
Frequently asked questions
It is a medical field defined by specific disease types, symptoms or organ systems. Focusing on therapeutic areas helps concentrate research, resources and expertise to improve outcomes for patients with similar conditions.
We focus primarily on dermatology, particularly chronic inflammatory skin conditions. This includes both common and more complex skin diseases, where there is still a significant need for better treatment options.
Skin conditions can deeply affect patients’ quality of life, so we strive to develop effective treatments. Our ambition is not only to relieve symptoms, but also to help patients feel more confident, comfortable and in control of their disease.
While dermatology is our core focus, we support additional areas based on market and clinical needs. These activities are evaluated carefully to ensure they align with our expertise and can deliver meaningful benefits for patients.
Psoriasis, atopic dermatitis, actinic keratosis, acne and other inflammatory dermatoses. We also explore related conditions where our scientific knowledge and technologies can be applied to improve treatment options.
We prioritize unmet needs, scientific opportunity and patient impact. Decisions are guided by clinical evidence, input from experts and the potential to deliver long-term health benefits.
Yes, dermatologists and healthcare professionals guide research and understanding of clinical practice. Their real-world experience helps us design better studies, develop relevant treatments and provide practical information for daily clinical use.
We aim to address underserved conditions where possible. You can find more information in our rare skin diseases section, where we highlight specific initiatives, research projects and partnerships focused on these patients.
Specialization leads to greater expertise, investment and consistent improvement in care. This focus helps accelerate innovation, improve treatment guidelines and provide more tailored solutions for patients.
Yes, through our medical information services and professional resources. These include scientific materials, educational content and support for evidence-based decision-making in clinical practice.
Some may be authorized for paediatric use where supported by evidence and regulation. The approved age ranges and indications are specified in each product’s prescribing information, and healthcare professionals should always follow local guidelines.
We collaborate with patient groups to raise awareness and improve support services. Working together, we aim to better understand patient needs, promote education and contribute to initiatives that enhance quality of life.
Need to speak with our team?
For more information about our products, research, or strategic initiatives, please contact our Investor Relations team or our commercial and medical experts, who are available to assist with your enquiries.